EDGAR Filing Documents for 0001654954-18-001972

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001654954-18-001972

Filing Date

2018-02-28

Accepted

2018-02-28 17:07:57

Documents

Period of Report

2016-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q/A	oxis_10q.htm	10-Q/A	621010
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	oxis_ex311.htm	EX-31.1	18849
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	oxis_ex312.htm	EX-31.2	18793
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	oxis_ex321.htm	EX-32.1	7625
5	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	oxis_ex322.htm	EX-32.2	7618
	Complete submission text file	0001654954-18-001972.txt		2001314

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	gtbp-20160930.xml	EX-101.INS	226974
7	XBRL TAXONOMY EXTENSION SCHEMA	gtbp-20160930.xsd	EX-101.SCH	18290
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	gtbp-20160930_cal.xml	EX-101.CAL	33880
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	gtbp-20160930_def.xml	EX-101.DEF	41051
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	gtbp-20160930_lab.xml	EX-101.LAB	151301
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	gtbp-20160930_pre.xml	EX-101.PRE	116057

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)